Scott Borland, SVP, Neurology Franchise at MAP Pharmaceuticals, Inc. (MAPP), sold 2,081 shares at $24.75 ($52K) on 2013-01-26, disclosed to the SEC on 2013-01-29.
Open-market sale of $52k MAPP by SVP, Neurology Franchise. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.75 | 1,317 | $33K | 63.3% |
| 2 | $24.75 | 764 | $19K | 36.7% |
| Total | $24.75 avg | 2,081 | $52K | 100% |